<scp><i>BRCA</i></scp><i>1</i> and <scp><i>BRCA</i></scp><i>2</i> mutations in <scp>J</scp>apanese patients with ovarian, fallopian tube, and primary peritoneal cancer

Abstract

In this unselected Japanese population, approximately 13% of the cases with ovarian cancer appeared to be associated with an inherited risk, regardless of a family history. This finding indicates that BRCA1/2 genetic testing should be performed for all patients with ovarian cancers.